; The mission of the Developmental Core (Core B) is to foster and support innovative, interdisciplinaiy research into the pathogenesis, prevention and treatment of HIV/AIDS by Penn CFAR investigators;enhance the cadre of investigators studying HIV/AIDS by providing support and leadership for emerging investigators and facilitating entry into the field by researchers in other areas;and encourage and support innovative research in scientific priorities areas identified through CFAR strategic planning. In order to achieve these goals, the Developmental Core carries out three Specific Aims: (1) a Pilot Grant awards program that funds up to 6 developmental grants each year, evaluated through a rigorous peer review process for scientific merit and concordance with the mission of the Developmental Core and scientific priorities of the CFAR;(2) a Mentoring program to provide advice, support and leadership for the next generation of investigators to facilitate their transition into independent research careers in HIV/AIDS, and;(3) a series of workshops, working groups and outreach activities designed to bring together investigators from different but potentially interrelated areas to foster interdisciplinary interactions. In the 14 years since the Penn CFAR's inception (FY2000-2013), the Developmental Core has supported 77 pilot projects that have resulted in significant new knowledge of HIV/AIDS: supported the development of research priorities identified through the CFAR strategic planning process: served as the springboard to independent research careers of junior scientists: and led to subsequent funding of multiple research grants from NIH and other sources with an investment of $2.9M in pilot funding and a total of $55 million in new funding, for a 19 to 1 return on investment in developmental funding support. In the coming cycle, the Developmental Core will continue with its successful pilot grant program, will enhance our junior investigator mentoring program, and continue to serve as a vehicle for realizing priorities and initiatives critical for the interactive research program on campus.
;Core B's mission is to promote innovative research into the pathogenesis, prevention and treatment of HIV/AIDS, support the development of the next generation of researchers, and foster research focused on CFAR key scientific priorities. To achieve these goals, the Core will: 1) mentor Junior investigators and bring investigators in other fields into HIV research, 2) promote new collaborative initiatives among CFAR investigators, and 3) provide seed funds to accomplish these goals through a pilot grant funding program.
|Gross, Robert; Bandason, Tsitsi; Langhaug, Lisa et al. (2015) Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care 27:322-6|
|Muluneh, Melaku; Shang, Wu; Issadore, David (2014) Track-etched magnetic micropores for immunomagnetic isolation of pathogens. Adv Healthc Mater 3:1078-85|
|Safren, Steven A; Biello, Katie B; Smeaton, Laura et al. (2014) Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One 9:e104178|
|Nachega, Jean B; Parienti, Jean-Jacques; Uthman, Olalekan A et al. (2014) Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 58:1297-307|
|Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J et al. (2014) Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther 19:141-7|
|Zetola, Nicola M; Modongo, Chawangwa; Olabiyi, Bisayo et al. (2014) Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge. Sex Transm Infect 90:216-22|
|Haas, David W; Kwara, Awewura; Richardson, Danielle M et al. (2014) Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes. J Antimicrob Chemother 69:2175-82|
|Ramirez, Lorenzo A; Daniel, Alexander; Frank, Ian et al. (2014) Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. J Infect Dis 210:646-50|
|Liu, Weimin; Li, Yingying; Shaw, Katharina S et al. (2014) African origin of the malaria parasite Plasmodium vivax. Nat Commun 5:3346|
|Blank, Michael B; Hennessy, Michael; Eisenberg, Marlene M (2014) Increasing quality of life and reducing HIV burden: the PATH+ intervention. AIDS Behav 18:716-25|
Showing the most recent 10 out of 235 publications